Jiangyang Chi

933 total citations
20 papers, 742 citations indexed

About

Jiangyang Chi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Jiangyang Chi has authored 20 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cell Biology. Recurrent topics in Jiangyang Chi's work include Medicinal Plants and Bioactive Compounds (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Jiangyang Chi is often cited by papers focused on Medicinal Plants and Bioactive Compounds (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Jiangyang Chi collaborates with scholars based in China. Jiangyang Chi's co-authors include Shasha Xing, Fang Bian, Si Jin, Yonghui Zhang, Tao Zheng, Wenjing Li, Dan Wu, Xiaoyan Yang, Gao Xu and Xiangli Bai and has published in prestigious journals such as British Journal of Pharmacology, Cardiovascular Research and Experimental Cell Research.

In The Last Decade

Jiangyang Chi

20 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangyang Chi China 12 424 145 128 122 111 20 742
Xiangli Bai China 16 449 1.1× 147 1.0× 118 0.9× 106 0.9× 138 1.2× 24 769
Minglu Liang China 20 441 1.0× 128 0.9× 104 0.8× 118 1.0× 62 0.6× 52 884
Baochang Lai China 15 400 0.9× 114 0.8× 79 0.6× 166 1.4× 57 0.5× 41 821
Shasha Xing China 15 633 1.5× 205 1.4× 152 1.2× 180 1.5× 168 1.5× 30 1.1k
Hu Xu China 16 245 0.6× 119 0.8× 118 0.9× 90 0.7× 71 0.6× 41 687
Yingdong Lu China 15 462 1.1× 59 0.4× 150 1.2× 63 0.5× 64 0.6× 28 871
Minna Woo Canada 16 339 0.8× 225 1.6× 70 0.5× 115 0.9× 139 1.3× 32 910
Zeenat S. Hakim United States 13 391 0.9× 87 0.6× 148 1.2× 192 1.6× 112 1.0× 14 941

Countries citing papers authored by Jiangyang Chi

Since Specialization
Citations

This map shows the geographic impact of Jiangyang Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangyang Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangyang Chi more than expected).

Fields of papers citing papers by Jiangyang Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangyang Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangyang Chi. The network helps show where Jiangyang Chi may publish in the future.

Co-authorship network of co-authors of Jiangyang Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangyang Chi. A scholar is included among the top collaborators of Jiangyang Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangyang Chi. Jiangyang Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qingpeng, et al.. (2025). CTRP3 attenuates myocardial lipotoxicity via suppression of lipid accumulation, inflammation, apoptosis, and mitochondrial oxidative stress. Frontiers in Cardiovascular Medicine. 12. 1575929–1575929. 1 indexed citations
2.
Chi, Jiangyang, et al.. (2024). The Utility of the Vasoactive-Inotropic Score and Its Nomogram in Guiding Postoperative Management in Heart Transplant Recipients. Transplant International. 37. 11354–11354. 1 indexed citations
3.
4.
Chen, Shiqi, Kan Wang, Zhengfeng Fan, et al.. (2024). Modulation of anti-cardiac fibrosis immune responses by changing M2 macrophages into M1 macrophages. Molecular Medicine. 30(1). 88–88. 9 indexed citations
5.
Lin, Shuang, Chenyang Wang, Xueke Zhang, et al.. (2024). Discovery of novel natural cardiomyocyte protectants from a toxigenic fungus Stachybotrys chartarum. Bioorganic Chemistry. 148. 107461–107461. 4 indexed citations
6.
Chen, Xing, Jiangyang Chi, Fengli Li, et al.. (2023). Platelet membrane-coated alterbrassicene A nanoparticle inhibits calcification of the aortic valve by suppressing phosphorylation P65 NF-κB. Theranostics. 13(11). 3781–3793. 13 indexed citations
7.
Chi, Jiangyang, Yixuan Zhao, Rui Jiang, et al.. (2023). Indoloquinazoline alkaloids with cardiomyocyte protective activity against cold ischemic injury from Aspergillus clavatonanicus. Bioorganic Chemistry. 135. 106482–106482. 8 indexed citations
8.
Xu, Li, Yu Feng, Jiangyang Chi, et al.. (2023). Donor circadian clock influences the long-term survival of heart transplantation by immunoregulation. Cardiovascular Research. 119(12). 2202–2212. 3 indexed citations
9.
Chi, Jiangyang, et al.. (2023). Natural Oncolysis of Enterovirus 71 in Antitumor Therapy of Colorectal Cancer. Advanced Biology. 7(7). e2200336–e2200336. 3 indexed citations
10.
Chen, Shiqi, Jingwei Ma, Jiangyang Chi, et al.. (2022). Roles and potential clinical implications of tissue transglutaminase in cardiovascular diseases. Pharmacological Research. 177. 106085–106085. 11 indexed citations
11.
Chi, Jiangyang, et al.. (2022). Epicardial Adipose Tissue in Patients with Coronary Artery Disease: A Meta-Analysis. Journal of Cardiovascular Development and Disease. 9(8). 253–253. 15 indexed citations
12.
Zhang, Hongyan, Jiangyang Chi, Jia Hu, et al.. (2021). Intracellular AGR2 transduces PGE2 stimuli to promote epithelial–mesenchymal transition and metastasis of colorectal cancer. Cancer Letters. 518. 180–195. 21 indexed citations
13.
Chi, Jiangyang, Hongyan Zhang, Jia Hu, et al.. (2019). AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling. Cellular Signalling. 65. 109419–109419. 23 indexed citations
14.
Li, Jing, Jia Hu, Zhen Luo, et al.. (2019). AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer. Experimental Cell Research. 385(1). 111644–111644. 13 indexed citations
15.
Xing, Shasha, Xiaoyan Yang, Tao Zheng, et al.. (2015). Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway. Vascular Pharmacology. 72. 141–152. 86 indexed citations
16.
Wu, Dan, Xiaoyan Yang, Tao Zheng, et al.. (2015). A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells. American Journal of Physiology-Endocrinology and Metabolism. 310(3). E225–E237. 42 indexed citations
17.
Zheng, Tao, Xiaoyan Yang, Dan Wu, et al.. (2015). Salidroside ameliorates insulin resistance through activation of a mitochondria‐associated AMPK/PI3K/Akt/GSK3β pathway. British Journal of Pharmacology. 172(13). 3284–3301. 199 indexed citations
18.
Zhang, Youzhi, Xiaoyan Yang, Fang Bian, et al.. (2014). TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: Crosstalk between NF-κB and PPAR-γ. Journal of Molecular and Cellular Cardiology. 72. 85–94. 159 indexed citations
19.
Bian, Fang, Xiaoyan Yang, Fan Zhou, et al.. (2014). C‐reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells. British Journal of Pharmacology. 171(10). 2671–2684. 70 indexed citations
20.
Xing, Shasha, Xiaoyan Yang, Wenjing Li, et al.. (2014). Salidroside Stimulates Mitochondrial Biogenesis and Protects against H2O2-Induced Endothelial Dysfunction. Oxidative Medicine and Cellular Longevity. 2014. 1–13. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangli Bai Breakdown of academic impact, for papers by Minglu Liang Breakdown of academic impact, for papers by Baochang Lai Breakdown of academic impact, for papers by Shasha Xing Breakdown of academic impact, for papers by Hu Xu Breakdown of academic impact, for papers by Yingdong Lu Breakdown of academic impact, for papers by Minna Woo Breakdown of academic impact, for papers by Zeenat S. Hakim
Rankless by CCL
2026